miR-29 therapeutic

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemiR-29 therapeutic
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionFibroblast modulators
TargetsUpdating
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of ZurichUnitectra
Active IndicationsN/A
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A